Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT00922818

Study of Anatomic Nerve Sparing Radical Perineal Prostatectomy

Clinical Outcomes for Anatomic Nerve Sparing Radical Perineal Prostatectomy

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Maimonides Medical Center · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

Our objective is to evaluate the clinical outcomes for the anatomic radical perineal prostatectomy (RPP) for the surgical management of prostate cancer. We will report the perioperative, oncologic, and functional outcomes in patients undergoing the radical perineal prostatectomy at our institution.

Detailed description

The purpose of our study is to evaluate perioperative, oncologic, and functional outcomes for the anatomic radical perineal prostatectomy. The anatomic radical perineal prostatectomy is standard-of-care surgical approach to the surgical management of localized prostate cancer. The operative technique selected for radical prostatectomy is largely based on patient preference after appropriate counseling, and surgeon recommendation based on surgical considerations and surgeon experience. Outcome data for the anatomic radical perineal prostatectomy will represent a valuable addition to the published body of literature. Our study is a prospective clinical outcome data collection and analysis and we will be looking at data within several domains. First, perioperative data will be collected to evaluate the OR time, blood loss, surgical complications, and length of hospital stay for the anatomic radical perineal prostatectomy. Second, oncologic efficacy of this procedure will be reported, based on margin status of surgical specimens, which will be correlated with tumor features (Gleason score, tumor volume, pre-op PSA score). Third, functional outcomes will be evaluated by comparing urinary, sexual, and bowel function in the pre-op and post-op settings. This third domain will be accomplished by employing the following validated questionnaires (attached - SHIM, IPSS, and EPIC-26). These questionnaires will be filled out at 3 time-points: pre-op, and at 3 months and 12 months post-operatively.

Conditions

Timeline

Start date
2009-06-01
Primary completion
2011-05-26
Completion
2011-05-26
First posted
2009-06-17
Last updated
2018-08-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00922818. Inclusion in this directory is not an endorsement.